Open AccessMonitoring and Improving Naltrexone Adherence in Patients with Substance Use Disorder
Author(s) -
Virginia Perez-Macia,
Mireia Martinez Cortes,
Jesus Mesones,
Manuel Segura-Trepichio,
Lorena Garcia-Fernandez
Publication year - 2021
Publication title -
patient preference and adherence
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.885
H-Index - 48
ISSN - 1177-889X
DOI - 10.2147/ppa.s277861
Subject(s) - naltrexone , medicine , opioid use disorder , alcohol use disorder , psychosocial , abstinence , psychiatry , opioid antagonist , population , opioid , alcohol , (+) naloxone , biochemistry , chemistry , receptor , environmental health
Naltrexone is an opioid antagonist used for the treatment of patients with opioid use disorder and alcohol use disorder. This population often presents problems of follow-up and therapeutic efficacy related to adherence to treatment. The purpose of our study is to provide an exhaustive summary of the current evidence regarding naltrexone adherence in people with substance use disorders and to identify possible variables that may influence adherence to naltrexone.